Abstract: A method is provided for characterising a gait comprising steps of: receiving a signal measuring the movement of a target subject measured beforehand; comparing (204) at least one section of the measuring signal with a plurality of reference signals, the plurality of reference signals comprising at least one movement signal measured beforehand on a reference subject different from the target subject, each comparison of the measuring signal with a reference signal producing a similarity coefficient representative of a probability of similarity between the compared signals; and selecting (208) at least one local maximum of interest among the similarity coefficients produced, wherein the plurality of reference signals comprises at least one movement signal measured beforehand on a reference subject afflicted with a gait disorder, and at least one movement signal measured beforehand on a healthy reference object.
Type:
Application
Filed:
August 5, 2016
Publication date:
August 9, 2018
Applicants:
Universite Paris Descartes, Centre National de la Recherche Scientifique (CNRS), Ecole Normale Superieure De Cachan, Etat Français - Ministére de la Défense - Direction centrale du service de santé des armées, Univ Paris XIII Paris-Nord Villetaneuse
Inventors:
Robert Dadashi, Thomas Moreau, Charles Truong, Catherine De Waele, Alain Yelnik, Rémi Barrois-Muller, Nicolas Vayatis, Laurent Oudre, Pierre Paul Vidal, Damien Ricard
Abstract: The disclosure relates to a method for transmitting an item of information in a communication channel linking a transmitter to a recipient, the method including the following successive steps: the determination, by the transmitter, of a first intelligible sound signal representative of the item of information to be transmitted, the acoustic processing, by the transmitter, of the first sound signal so as to produce a second sound signal unintelligible to the recipient, the transmission of the second sound signal from the transmitter to the recipient, the transmission of the first sound signal from the transmitter to the recipient, the transmission of the first sound signal being triggered by the transmission of the second sound signal, the second transmission of the second sound signal from the transmitter to the recipient, the second transmission of the second sound signal being triggered by the transmission of the first signal.
Type:
Application
Filed:
July 8, 2016
Publication date:
July 26, 2018
Applicants:
URGO RECHERCHE INNOVATION ET DEVELOPPEMENT, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), ECOLE NORMALE SUPERIEURE, ECOLE SUPERIEURE DE PHYSIQUE ET DE CHIMIE INDUSTRIELLES DE LA VILLE DE PARIS, UNIVERSITE PARIS DIDEROT - PARIS 7
Inventors:
Daniel PRESSNITZER, Laure CORNU, Hervé LE LOUS
Abstract: A method of characterizing a part including obtaining an X-ray tomography image of the part and then a step of correlating the image with a reference wherein the correlation step includes searching among a predefined set of X-ray tomography image transformations for a transformation that minimizes the difference between the image and the reference in order to characterize the inside of the part.
Type:
Application
Filed:
December 9, 2014
Publication date:
July 12, 2018
Applicants:
SNECMA, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, ECOLE NORMALE SUPERIEURE DE CACHAN
Inventors:
Julien SCHNEIDER, Francois HILD, Hugo LECLERC, Stephane ROUX
Abstract: The invention relates to human neutralizing anti-KIT antibodies and uses thereof. More particularly, the invention relates to an antibody comprising a heavy chain variable region comprising SEQ ID NO: 2 in the H-CDR1 region, SEQ ID NO: 3 in the H-CDR2 region and SEQ ID NO: 4 in the H-CDR3 region; and a light chain variable region comprising SEQ ID NO: 6 in the L-CDR1 region, SEQ ID NO: 7 in the L-CDR2 region and SEQ ID NO: 8 in the L-CDR3 region. The invention also relates to an antibody comprising a heavy chain variable region comprising SEQ ID NO: 10 in the H-CDR1 region, SEQ ID NO: 11 in the H-CDR2 region and SEQ ID NO: 12 in the H-CDR3 region; and a light chain variable region comprising SEQ ID NO: 14 in the L-CDR1 region, SEQ ID NO: 15 in the L-CDR2 region and SEQ ID NO: 16 in the L-CDR3 region.
Type:
Grant
Filed:
November 5, 2014
Date of Patent:
April 3, 2018
Assignees:
INSERM (Institut National de la Sante et de la Recherche Medicale, Centre National de la Recherche Scientifique (CNRS), Universite de Montpellier, Universite Paris- Sud, Institut Regional du Cancer du Montpellier, Ecole Normale Superieure de Cachan
Inventors:
Marie-Alix Poul, Mariane Le Gall, Ronan Crepin
Abstract: The present invention relates to a method for determining whether a protein binds to a specific DNA sequence. This method is useful in particular for identifying modifications to the DNA sequence (e.g. methylations) via the binding of proteins that specifically recognize those modifications (e.g. antibodies), but also to identify the binding sequence on DNA of a variety of proteins.
Type:
Grant
Filed:
January 22, 2014
Date of Patent:
March 13, 2018
Assignees:
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), ECOLE NORMALE SUPERIEURE, UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6)
Inventors:
David Bensimon, Vincent Croquette, Harold Gouet, Jean-Francois Allemand, Fang-Yuan Ding
Abstract: Disclosed is a method for measuring movement and/or deformation of a study part subjected to an external stress, the method implementing a color digital image acquisition device and image correlation unit. The method includes: acquisition (250) of a plurality of color digital images of the surface of the study part by way of the color digital image acquisition device during the application of an external stress on the study part, and processing (260) of the color digital images acquired in the step of acquisition of a plurality of color digital images so as to highlight contrasting details on variable scales.
Type:
Grant
Filed:
July 9, 2014
Date of Patent:
December 26, 2017
Assignees:
AIRBUS GROUP SAS, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, ECOLE NORMALE SUPERIEURE DE CACHAN
Abstract: The present invention relates to a therapeutic compound comprising: an agent that inhibits the activity of at least one gene selected from the group consisting of HIC1, FOXS1, CREB5, IRF7, POU2F2, STAT4, TCF4, and/or an agent that enhances the activity of at least one gene selected from the group consisting of MAF, MEOX2, SIX2.
Type:
Grant
Filed:
July 30, 2014
Date of Patent:
December 12, 2017
Assignees:
Centre National de la Recherche Scientifique-CNRS CNRS, INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE), URGO RECHERCHE INNOVATION ET DEVELOPPEMENT, UNIVERSITÉ PARIS DIDEROT—PARIS 7, ECOLE NORMALE SUPERIEURE
Abstract: Methods for diagnosing and treating CD1d-restricted gamma/delta T cell lymphomas are disclosed. In particular, the present disclosure relates to a method for diagnosing a T cell lymphoma as a CD1d-restricted gamma/delta T cell lymphoma in a patient in need thereof including i) detecting the presence of CD1d restricted gamma/delta T lymphoma cells in a cell lymphoma sample obtained from the patient and ii) concluding that the T cell lymphoma is a CD1d-restricted gamma/delta T cell lymphoma when the presence of CD1d restricted gamma/delta T cells is detected in the sample. The present disclosure also relates to a method for treating a CD1d-restricted gamma/delta T cell lymphoma as diagnosed by the diagnostic method, including administering the patient with a therapeutically effective amount of a CD1d antagonist.
Type:
Application
Filed:
January 23, 2017
Publication date:
November 9, 2017
Applicants:
Institut National De La Santé Et De La Recherche Médicale (INSERM), Université Claude Bernard Lyon 1, Ecole Normale Supérieure De Lyon, Centre National De La Recherche Scientifique (CNRS)
Abstract: A visualization kit includes (i) a cyanoacrylate and (ii) a fluorescent agent containing at least one tetrazine of formula 1: wherein X and Y represent independently a nonionic, electron-withdrawing group selected from halogens, azide, cyano and O-A-R, in which A represents a single bond or a C1-C4 alkyldiyl and R is alkyl, alkenyl, alkynyl, cycloalkyl or epoxyalkyl, or an aziridine group, which is optionally substituted by alkyl or aryl. A method of cofugation and a method of visualizing traces on a substrate utilizing these components are also presented.
Type:
Grant
Filed:
March 6, 2012
Date of Patent:
October 17, 2017
Assignees:
CRIME SCIENCE TECHNOLOGY, ECOLE NORMALE SUPERIEURE DE CACHAN, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE—CNRS
Inventors:
Cosimo Prete, Pierre Audebert, Laurent Galmiche, Clemence Allain
Abstract: The subject matter of the present invention is compounds which have a 6-aminopurine backbone corresponding to formula (I): in which R1, R2, R3, X, Y and Z are as defined in any one of claims 1 to 5, and Ar is a biphenyl or a naphthyl which may be substituted with R3, for use in the treatment of cancer.
Type:
Grant
Filed:
September 29, 2014
Date of Patent:
October 10, 2017
Assignees:
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE-CNRS, HOSPICES CIVILS DE LYON, ECOLE NORMALE SUPERIEURE DE LYON, UNIVERSITE CLAUDE BERNARD LYON 1, UNIVERSITE DE MONTPELLIER 1
Inventors:
Laurent Chaloin, Suzanne Peyrottes, Corinne Lionne, Zsuzsanna Marton, David Egron, Remi Guillon, Christian Perigaud, Charles Dumontet, Lars Petter Jordheim, Isabelle Krimm
Abstract: The present invention relates to a method for the determination of a nucleic acid sequence by physical manipulation. In particular, the said method comprises the steps of denaturing a double-stranded nucleic acid molecule corresponding to the said nucleic acid sequence by applying a physical force to the said molecule; and detecting a blockage of the renaturation of the double-stranded nucleic acid molecule. More specifically, the method comprises the steps of denaturing a double-stranded nucleic acid molecule corresponding to the said nucleic acid sequence by applying a physical force to the said molecule; providing a single-stranded nucleic acid molecule; renaturing the said double stranded nucleic acid molecule in the presence of the said single-stranded nucleic acid molecule; and detecting a blockage of the renaturation of the double-stranded nucleic acid.
Type:
Grant
Filed:
October 26, 2016
Date of Patent:
September 19, 2017
Assignees:
CENTRE NATIONAL DE LA RECERCHE SCIENTIFIQUE (CNRS), ECOLE NORMALE SUPERIEURE, UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6)
Inventors:
David Bensimon, Vincent Croquette, Jean-Francois Allemand, Maria Manosas, Fang-Yuan Ding
Abstract: The present invention relates to a fast method for the detection and the quantification of a nucleic acid, DNA or RNA. Specifically, the invention provides a method for detecting and quantifying the presence of a specific nucleic acid molecule which is based on physical and electronic treatments. The method of the invention is particularly useful for applications as diverse as detection of chromosomal abnormal distributions or gene expression analysis.
Type:
Grant
Filed:
December 21, 2012
Date of Patent:
August 22, 2017
Assignees:
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), ECOLE NORMALE SUPERIEURE, UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6)
Inventors:
David Bensimon, Jean-Francois Allemand, Fang-Yuan Ding, Vincent Croquette
Abstract: The present invention relates to a method for the determination of a nucleic acid sequence by physical manipulation. The method is based on the precise determination of the localization of the replicating fork on the template by measuring the physical distance between one end of the molecule and the fork. This allows the determination of the physical location of the site where a pause or a blockage of the replication occurs, and deducing therefrom information on the sequence of the nucleic acid.
Type:
Grant
Filed:
October 26, 2016
Date of Patent:
August 22, 2017
Assignees:
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), ECOLE NORMALE SUPERIEURE, UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6)
Inventors:
David Bensimon, Vincent Croquette, Jean-Francois Allemand, Maria Manosas, Fang-Yuan Ding
Abstract: In the field of methods of three-dimensional measurement of an object by stereo-correlation, methods require at least two cameras connected to image processing means. These methods include at least a first step of calibration of the two image planes and a second step of spatial matching between these two image planes. These two steps can be followed by a third step of temporal matching. The method provided requires objects, the surface of which has a parametric representation, i.e. a mathematical representation of the object surface having the form of a decomposition over a scalar function basis. The parametric representation is implemented during the first calibration step and/or during the second and third steps of spatial or temporal matching.
Type:
Grant
Filed:
May 24, 2013
Date of Patent:
August 15, 2017
Assignees:
Centre National De La Recherche Scientifique, Ecole Normale Superieure de Cachan
Abstract: Disclosed is a method of oxidizing a cycloalkane to form a product mixture containing a corresponding alcohol and ketone, said method comprising contacting a cycloalkane with a hydroperoxide in the presence of a catalytic effective amount of a crystalline MWW-type titanosilicate catalyst. Hydroperoxides may notably be tert-butyl hydroperoxide, tert-amyl hydroperoxide, cumene hydroperoxide, ethylbenzene hydroperoxide, cyclohexyl hydroperoxide, methylcyclohexyl hydroperoxide, tetralin hydroperoxide, isobutylbenzene hydroperoxide, and ethylnaphthalene hydroperoxide.
Type:
Grant
Filed:
July 26, 2012
Date of Patent:
July 18, 2017
Assignees:
Rhodia Operations, East China Normal University, Ecole Normale Superieure De Lyon
Inventors:
Floryan Decampo, Wenjuan Zhou, Peng Wu, Kai Xue, Yueming Liu, Mingyuan He
Abstract: The invention provides probes with formula (I): in which: X1?NH, O, or S; X2?O or S; SE is a labile group, which may be eliminated under the action of a stimulus that may in particular be the presence of an enzyme, a chemical compound, or a physicochemical characteristic of the medium in which the probe is located; A is an aromatic group that, following cleavage of the C(X2)—O bond in aqueous solution, leads to the liberation of a chromophore or a fluorophore, R represents a hydrogen atom or -(L)n-GP, in which n is equal to 0 or 1, L is a linker arm, and GP is a hydrosolubilizing group; as well as their physiologically acceptable salts, solvates, or hydrates. The invention also provides intermediates for the synthesis thereof and detection methods employing them.
Type:
Application
Filed:
June 24, 2015
Publication date:
June 8, 2017
Applicants:
ECOLE NORMALE SUPERIEURE DE LYON, UNIVERSITE CLAUDE BERNARD LYON I, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
Abstract: The invention relates to novel peptidase substrates of formula (I): wherein R0, R1, R2, R3, R4, R5 and n are as defined in claim 1, and a method for detecting the presence of a catalytically active peptidase, by means of one of these substrates.
Type:
Grant
Filed:
September 27, 2012
Date of Patent:
March 28, 2017
Assignees:
ECOLE NORMALE SUPERIEURE DE LYON, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
Abstract: The disclosure provides a method of delivering a polypeptide molecule to an Otx2 target cell, including contacting the target cell with a chimeric polypeptide having (i) a targeting peptide consisting of SEQ ID NO: 2 and (ii) the polypeptide molecule.
Type:
Application
Filed:
September 29, 2016
Publication date:
March 23, 2017
Applicants:
Centre National de la Recherche Scientifique, Ecole Normale Superieure
Inventors:
Alain Prochiantz, Ariel Di Nardo, Marine Beurdeley
Abstract: The invention concerns novel glycosidase substrates of formula (I): where R0, R1, R2, R3, and R4 are such as defined in claim 1; and a method for detecting the presence of a catalytically active glycosidase using one of these substrates.
Type:
Grant
Filed:
July 31, 2013
Date of Patent:
March 14, 2017
Assignees:
ECOLE NORMALE SUPERIEURE DE LYON, UNIVERSITE CLAUDE BERNARD LYON I, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
Abstract: The invention concerns a new class of tubulin polymerisation inhibitors and their applications in research and medicine, notably in chemotherapy. The invention proposes new azoaryl derivatives of formula (I): as defined in Claim 1, which may be fully reversibly interconverted between non-tubulin-binding trans and tubulin-binding as isomeric forms, either by irradiation or spontaneously.
Type:
Application
Filed:
April 29, 2014
Publication date:
February 23, 2017
Applicants:
ECOLE NORMALE SUPERIEURE DE LYON, UNIVERSITE CLAUDE BERNARD LYON I, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN
Inventors:
Oliver THORN-SESHOLD, Malgorzata BOROWIAK, Dirk TRAUNER, Jens HASSERODT